A weblog devoted (mainly) to visual communications in the pharmaceutical, biotech and healthcare sectors. Edited by Lee W. Potts.

Jabber ID: jabber@leepotts.com

Resume / Portfolio / Projects

Opinions expressed on this weblog are mine alone and do not necessarily reflect the views of my employer.

Search


Blogroll Me Technorati Profile Powered by Blogger Pro Blogwise DreamHost Web Hosting check out my neighbors in meatspace Creative Commons License Subscribe with Bloglines The Eyes Have It The Eyes Have It Flickr page
Donate towards my web hosting bill!

Referrers & Reciprocals

Other Links

Archives

05/01/2002 - 05/31/2002 06/01/2002 - 06/30/2002 07/01/2002 - 07/31/2002 08/01/2002 - 08/31/2002 09/01/2002 - 09/30/2002 10/01/2002 - 10/31/2002 11/01/2002 - 11/30/2002 12/01/2002 - 12/31/2002 01/01/2003 - 01/31/2003 02/01/2003 - 02/28/2003 03/01/2003 - 03/31/2003 04/01/2003 - 04/30/2003 05/01/2003 - 05/31/2003 06/01/2003 - 06/30/2003 07/01/2003 - 07/31/2003 08/01/2003 - 08/31/2003 09/01/2003 - 09/30/2003 10/01/2003 - 10/31/2003 11/01/2003 - 11/30/2003 12/01/2003 - 12/31/2003 01/01/2004 - 01/31/2004 02/01/2004 - 02/29/2004 03/01/2004 - 03/31/2004 04/01/2004 - 04/30/2004 05/01/2004 - 05/31/2004 07/01/2004 - 07/31/2004 08/01/2004 - 08/31/2004 09/01/2004 - 09/30/2004 10/01/2004 - 10/31/2004

Asides:

General design resources, quick links, digressions, off-topic stuff. [XML]

This page is part of the first version of The Eyes Have It which is no longer being updated. All legacy posts as well as all new material can be found at the new WordPress-powered version located at http://www.leepotts.com/tehi/. Please update your bookmarks.


Design Firms Beginning to Penetrate the Pharma Product Branding Area

Short article on the Design Management Institute website by By Ken DeLor (President, The DeLor Group) briefly outlines how the pharmaceutical industry is beginning to realize that developing a strong a visual identity for their products is crucial.

"Development of a visual identity for a pharmaceutical product historically has been a low priority, with scientists often naming the product and a visual identity coming as an afterthought, with little impact other than appearing as a “bug” at the bottom of a print ad."

Comments | Link Cosmos | Permalink | 10/23/2002 10:16:42 AM